Telix Pharmaceuticals (ASX:TLX) will change its reporting currency to US dollars from Australian dollars, effective Jan. 1, according to a Tuesday Australian bourse filing.

The change allows the company to align to the predominant currency used for reporting revenue, costs, and corresponding cash flows, which are primarily generated in the US, the filing added.

The company will also convert the comparative periods in upcoming financial results to US dollars, per the filing.

The company's shares fell almost 1% in recent Tuesday trade but earlier hit an all-time high.